Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Byrd

Showing results (491-500 of 1,058) with videos related to

Pageof 106
Sort By:
Blood|April 27, 2022
Subclonal evolution of CLL driver mutations is associated with relapse in ibrutinib- and acalabrutinib-treated patientsGage S Black, Xiaomeng Huang, Yi Qiao, et al.
Leukemia & Lymphoma|April 4, 2013
Patients with chronic lymphocytic leukemia with high-risk genomic features have inferior outcome on successive Cancer and Leukemia Group B trials with alemtuzumab consolidation: subgroup analysis from CALGB 19901 and CALGB 10101Jeffrey A Jones, Amy S Ruppert, Weiqiang Zhao, et al.
Blood|October 24, 2002
Randomized phase 2 study of fludarabine with concurrent versus sequential treatment with rituximab in symptomatic, untreated patients with B-cell chronic lymphocytic leukemia: results from Cancer and Leukemia Group B 9712 (CALGB 9712)John C Byrd, Bercedis L Peterson, Vicki A Morrison, et al.
Blood|August 4, 2005
Durable hematologic complete response and suppression of HTLV-1 viral load following alemtuzumab in zidovudine/IFN-{alpha}-refractory adult T-cell leukemiaAndrew Mone, Shannon Puhalla, Susan Whitman, et al.
Oncotarget|January 19, 2015
Up-regulation of CDK9 kinase activity and Mcl-1 stability contributes to the acquired resistance to cyclin-dependent kinase inhibitors in leukemiaYuh-Ying Yeh, Rong Chen, Joshua Hessler, et al.
Cancer|May 31, 2007
Hyperglycemia in patients with acute myeloid leukemia is associated with increased hospital mortalityNaeem A Ali, James M O'Brien, William Blum, et al.
Cancer|May 22, 2007
Pentostatin, cyclophosphamide, and rituximab regimen in older patients with chronic lymphocytic leukemiaTait D Shanafelt, Thomas Lin, Susan M Geyer, et al.
The Journal of Biological Chemistry|December 5, 1991
Molecular cloning of rat intestinal mucin. Lack of conservation between mammalian speciesJ R Gum, J W Hicks, R E Lagace, et al.
American Journal of Hematology|May 2, 2020
Management of CLL patients early in the COVID-19 pandemic: An international survey of CLL expertsBrian Koffman, Anthony Mato, John C Byrd, et al.
Oncoimmunology|November 18, 2016
Therapeutic CD94/NKG2A blockade improves natural killer cell dysfunction in chronic lymphocytic leukemiaEmily M McWilliams, Jennifer M Mele, Carolyn Cheney, et al.
Pageof 106

Showing results (491-500 of 1,058) with videos related to

Sort By:
Pageof 106
Blood|April 27, 2022
Subclonal evolution of CLL driver mutations is associated with relapse in ibrutinib- and acalabrutinib-treated patientsGage S Black, Xiaomeng Huang, Yi Qiao, et al.
Leukemia & Lymphoma|April 4, 2013
Patients with chronic lymphocytic leukemia with high-risk genomic features have inferior outcome on successive Cancer and Leukemia Group B trials with alemtuzumab consolidation: subgroup analysis from CALGB 19901 and CALGB 10101Jeffrey A Jones, Amy S Ruppert, Weiqiang Zhao, et al.
Blood|October 24, 2002
Randomized phase 2 study of fludarabine with concurrent versus sequential treatment with rituximab in symptomatic, untreated patients with B-cell chronic lymphocytic leukemia: results from Cancer and Leukemia Group B 9712 (CALGB 9712)John C Byrd, Bercedis L Peterson, Vicki A Morrison, et al.
Blood|August 4, 2005
Durable hematologic complete response and suppression of HTLV-1 viral load following alemtuzumab in zidovudine/IFN-{alpha}-refractory adult T-cell leukemiaAndrew Mone, Shannon Puhalla, Susan Whitman, et al.
Oncotarget|January 19, 2015
Up-regulation of CDK9 kinase activity and Mcl-1 stability contributes to the acquired resistance to cyclin-dependent kinase inhibitors in leukemiaYuh-Ying Yeh, Rong Chen, Joshua Hessler, et al.
Cancer|May 31, 2007
Hyperglycemia in patients with acute myeloid leukemia is associated with increased hospital mortalityNaeem A Ali, James M O'Brien, William Blum, et al.
Cancer|May 22, 2007
Pentostatin, cyclophosphamide, and rituximab regimen in older patients with chronic lymphocytic leukemiaTait D Shanafelt, Thomas Lin, Susan M Geyer, et al.
The Journal of Biological Chemistry|December 5, 1991
Molecular cloning of rat intestinal mucin. Lack of conservation between mammalian speciesJ R Gum, J W Hicks, R E Lagace, et al.
American Journal of Hematology|May 2, 2020
Management of CLL patients early in the COVID-19 pandemic: An international survey of CLL expertsBrian Koffman, Anthony Mato, John C Byrd, et al.
Oncoimmunology|November 18, 2016
Therapeutic CD94/NKG2A blockade improves natural killer cell dysfunction in chronic lymphocytic leukemiaEmily M McWilliams, Jennifer M Mele, Carolyn Cheney, et al.
Pageof 106